EPHA2 and sarcoma: In this study, we correlated EphA2 expression and NK cell score and observed a survival benefit in sarcoma patients with highest NK cell infiltration, assessed various EphA2‐targeting CAR designs for enhancing NK cell functionality against paediatric sarcoma in vitro and in vivo, and investigated how chemical modifications of mRNA can improve the stability and longevity of CAR expression.